MedPath

Determination of adequacy of analgesia in vaginal delivery with persistent intravenous analgesia with remifentanil compared to epidural analgesia

Phase 3
Conditions
Pain.
F45.4
Pain disorders related to psychological factors
Registration Number
IRCT20190325043107N14
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
65
Inclusion Criteria

Perform vaginal delivery

Exclusion Criteria

Women candidates for cesarean section

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: Every hour for two days. Method of measurement: Visual Analogue Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath